Heart Failure Is the Ideal Proving Ground for Clinical Agentic AI: The ARPA-H ADVOCATE Program
Journal of Cardiac Failure · 2026-11 · 32 (11) · 2010-2012
DOI: 10.1016/j.cardfail.2026.06.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-11. Verfasst von Haider J Warraich. Beteiligte Einrichtung: Advanced Research Projects Agency for Health, Washington, DC, USA. Electronic address: hwarraich@partners.org. Die Arbeit nennt 5 Literaturangaben. Gefördert von: NIH.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Research Projects Agency for Health, Washington, DC, USA. Electronic address: hwarraich@partners.org.
Förderung
- NIH
Zitieren
APA
Warraich, H. J. (2026). Heart Failure Is the Ideal Proving Ground for Clinical Agentic AI: The ARPA-H ADVOCATE Program. Journal of Cardiac Failure, 32(11), 2010-2012. https://doi.org/10.1016/j.cardfail.2026.06.031
Vancouver
Warraich HJ. Heart Failure Is the Ideal Proving Ground for Clinical Agentic AI: The ARPA-H ADVOCATE Program. Journal of Cardiac Failure. 2026;32(11):2010-2012. doi:10.1016/j.cardfail.2026.06.031
BibTeX
@article{Warraich2026,
author = {Warraich, Haider J},
title = {Heart Failure Is the Ideal Proving Ground for Clinical Agentic AI: The ARPA-H ADVOCATE Program},
journal = {Journal of Cardiac Failure},
year = {2026},
volume = {32},
number = {11},
pages = {2010--2012},
doi = {10.1016/j.cardfail.2026.06.031}
}
EUVIMED